Public Law 114-216 is a federal law of the United States that regulates GMO food labeling. It was enacted on July 29, 2016 when President Obama signed then Senate Bill 764 (S.764). While the law is officially termed A bill to reauthorize and amend the National Sea Grant College Program Act, and for other purposes, it evolved over time into "the legislative vehicle for a measure concerning bioengineered food disclosure", [1] which opponents have called the "DARK Act", an acronym for "Deny Americans the Right to Know Act". [2] [3] [4]
The bill was crafted by Senator Pat Roberts (R-KS) and Debbie Stabenow (D-MI). [5] The "GMO labeling bill" [6] was introduced on 17 March 2015 by its sponsor, Sen. Roger F. Wicker (R-MS), [1] cosponsored by Sen. Dan Sullivan (R-AK), and passed Senate and House in June 2016. The law overturned relevant state laws such as Vermont's GMO labeling law that had called for strict and transparent GMO food labeling in Vermont after July 1, 2016. [7]
Labeling of GMO food is mandated in at least 64 countries, including most European countries, China, Russia, Japan, Brazil, South Africa, and Australia. [2]
Senate resolution S.744 as originally introduced on 17 March 2015 contained no language to regulate bioengineered foods. [8] A bill entitled "Safe and Accurate Food Labeling Act of 2015" was received in the Senate on 24 July 2015 and referred to the Committee on Agriculture, Nutrition, and Forestry (ANF), which resulted in the amendments to Public Law 114-216 seen now; this was done on 7 July 2016 [9] to "establish a national bioengineered food disclosure standard", whereby bioengineered food (commonly referred to as genetically modified organism or GMO food) is defined as "food that has been genetically engineered in a way that could not be obtained through conventional breeding or found in nature". [1]
Mitch McConnell introduced on 29 June 2016 the "Roberts GMO bill" named after Pat Roberts who was then Chair of the Committee on ANF, [10] and Public Law 114-216 thereafter suffered through no less than 40 amendments over the course of one week. [11]
Public Law 114-216 charges the U. S. Department of Agriculture (USDA) to establish a national mandatory bioengineered food disclosure standard within two years with certain provisions: [1]
While the FDA is responsible for protecting and promoting public health through the control and supervision of food safety, the agency holds the position that "the use of genetic engineering in the production of food does not present any safety concerns for such foods as a class", and , as there is "an absence of reliable data indicating safety concerns" with GMO foods as a class, voiced no opposition for USDA having the responsibility of regulating GMO food labeling. [12] The agency commented that the bill has language that may allow GMO material to escape labeling: the bill requires labeling if the food contains "genetic material", but that may exempt secondary products like oil, starches, sweeteners, or proteins derived from GMO substrates. [12] The agency questioned the specificity of the definition of bioengineered food when it would not apply to GMOs that could also be achieved by "conventional breeding". [12] The FDA has also voiced some concerns about food information being presented in electronic codes. [12]
As the details of the law need to be worked out, USDA established a working group by September 2016 "to develop a timeline for rulemaking and to ensure an open and transparent process for effectively establishing this new program, which will increase consumer confidence and understanding of the foods they buy, and avoid uncertainty for food companies and farmers". [13]
Public Law 114-216 was passed after previous attempts to introduce a national GMO labeling bill had failed. It was fast-tracked without debate or committee review. [5] [14] The original bill S. 764 - "A bill to reauthorize and amend the National Sea Grant College Program Act, and for other purposes" - had nothing to do with food and stalled after having passed the Senate. Hollowed out of its content it was replaced with a bill to defund Planned Parenthood. [15] This bill was then replaced with a bill creating to outlaw state-level GMO labeling and setting a voluntary GMO labeling bill. [15] When this bill failed, the S. 764 husk was used to rush through the present bill, just in time before the Vermont GMO food labeling requirement would have been activated on July 1. [14]
Previous attempts to enact a national GMO labeling law included H. R. 1599 in 2017 – the Safe and Accurate Food Labeling Act of 2017. It was a proposed legislative amendment to the United States Federal Food, Drug and Cosmetic Act. [16] The act passed the House of Representatives on July 23, 2017 but failed in the Senate. An earlier version of the bill had been originally introduced as H. R. 4432 in 2004. [17] and attempted to regulate food labeling specifically in view of the introduction of GMO food in the United States.
Katie Hill, White House spokesperson, lauded the bill, "(t)his measure will provide new opportunities for consumers to have access to information about their food". [6] Proponents have argued for a comprehensive labeling law that applies nationwide instead of a "patchwork" approach state-by-state. [18] They also feel that a proposed bill will enhance agricultural biotechnology. [18]
Proponents argue that approved GMO food has undergone extensive testing, is "safe" and that basically labeling is unnecessary. Labeling may discourage consumers to use GMO products when such a choice may be irrational. A lot of consumers express fears that have not been substantiated by science. [19]
The bill is backed by Grocery Manufacturers Association, Monsanto, and other large food and beverage corporations. [3]
While GMOs are present in 75-80% of food Americans consume and have been termed "substantially equivalent" to the corresponding non-GMO foods by the FDA, consumers believe that they have a right to know what is in their food. [6] Thus, a 2013 poll by the New York Times indicated that ninety-three percent of American consumers would like to know if their food has been genetically modified. [19]
The primary objection to the bill is that manufacturers have the option to use electronic codes in lieu of clear readable labels placed directly on the food package, which they argue hides the information. [13] The bill allows the use codes such as the QR code as a form of labeling, and opponents see this as impractical as well as discriminatory. They argue that, for instance, low-income families may not be able to access the information. [6] Critics also oppose the fact that no fines or penalties are included when companies do not follow the law. [5] Additionally, they are concerned that the bill's stipulation that labeling will be required when foods contain genetic material from genetic modification may exempt many of the highly processed foods and ingredients that are usually derived from genetically-modified crops (such as many seed oils, high-fructose corn syrup, and some refined starches and sweeteners), because such foods are often sufficiently refined that no genetic material remains in them. [20] Senator Stabenow dismissed this interpretation when it was advanced by the FDA. [21]
Because clear and accessible labeling is not mandated, some opponents have called this bill and its predecessors the "DARK act" as in "Deny Americans the Right to Know" or "Keep Americans in the DARK". [2] [3] [4]
Genetically modified foods, also known as genetically engineered foods, or bioengineered foods are foods produced from organisms that have had changes introduced into their DNA using various methods of genetic engineering. Genetic engineering techniques allow for the introduction of new traits as well as greater control over traits when compared to previous methods, such as selective breeding and mutation breeding.
Charles Patrick Roberts is a retired American politician and journalist who served as a United States senator from Kansas from 1997 to 2021. A member of the Republican Party, Roberts served 8 terms in the U.S. House of Representatives, from 1981 to 1997, before his election to the Senate.
The United States Federal Food, Drug, and Cosmetic Act is a set of laws passed by the United States Congress in 1938 giving authority to the U.S. Food and Drug Administration (FDA) to oversee the safety of food, drugs, medical devices, and cosmetics. The FDA's principal representative with members of congress during its drafting was Charles W. Crawford. A principal author of this law was Royal S. Copeland, a three-term U.S. senator from New York. In 1968, the Electronic Product Radiation Control provisions were added to the FD&C. Also in that year the FDA formed the Drug Efficacy Study Implementation (DESI) to incorporate into FD&C regulations the recommendations from a National Academy of Sciences investigation of effectiveness of previously marketed drugs. The act has been amended many times, most recently to add requirements about bioterrorism preparations.
The Public Health Service Act is a United States federal law enacted in 1944. The full act is codified in Title 42 of the United States Code, Chapter 6A . This Act provided a legislative basis for the provision of public health services in the United States.
Genetically modified food controversies are disputes over the use of foods and other goods derived from genetically modified crops instead of conventional crops, and other uses of genetic engineering in food production. The disputes involve consumers, farmers, biotechnology companies, governmental regulators, non-governmental organizations, and scientists. The key areas of controversy related to genetically modified food are whether such food should be labeled, the role of government regulators, the objectivity of scientific research and publication, the effect of genetically modified crops on health and the environment, the effect on pesticide resistance, the impact of such crops for farmers, and the role of the crops in feeding the world population. In addition, products derived from GMO organisms play a role in the production of ethanol fuels and pharmaceuticals.
The Prescription Drug User Fee Act (PDUFA) was a law passed by the United States Congress in 1992 which allowed the Food and Drug Administration (FDA) to collect fees from drug manufacturers to fund the new drug approval process. The Act provided that the FDA was entitled to collect a substantial application fee from drug manufacturers at the time a New Drug Application (NDA) or Biologics License Application (BLA) was submitted, with those funds designated for use only in Center for Drug Evaluation and Research (CDER) or Center for Biologics Evaluation and Research (CBER) drug approval activities. In order to continue collecting such fees, the FDA is required to meet certain performance benchmarks, primarily related to the speed of certain activities within the NDA review process.
President of the United States George W. Bush signed the Food and Drug Administration Amendments Act of 2007 (FDAAA) on September 27, 2007. This law reviewed, expanded, and reaffirmed several existing pieces of legislation regulating the FDA. These changes allow the FDA to perform more comprehensive reviews of potential new drugs and devices. It was sponsored by Reps. Joe Barton and Frank Pallone and passed unanimously by the Senate.
Priority review is a program of the United States Food and Drug Administration (FDA) to expedite the review process for drugs that are expected to have a particularly great impact on the treatment of a disease. The priority review voucher program is a program that grants a voucher for priority review to a drug developer as an incentive to develop treatments for disease indications with limited profitability.
The United States is the largest grower of commercial crops that have been genetically engineered in the world, but not without domestic and international opposition.
Genetically modified canola is a genetically modified crop. The first strain, Roundup Ready canola, was developed by Monsanto for tolerance to glyphosate, the active ingredient in the commonly used herbicide Roundup.
The Food Safety Modernization Act (FSMA) was signed into law by President Barack Obama on January 4, 2011. The FSMA has given the Food and Drug Administration (FDA) new authority to regulate the way foods are grown, harvested and processed. The law grants the FDA a number of new powers, including mandatory recall authority, which the agency has sought for many years. The FSMA requires the FDA to undertake more than a dozen rulemakings and issue at least 10 guidance documents, as well as a host of reports, plans, strategies, standards, notices, and other tasks.
The regulation of genetic engineering varies widely by country. Countries such as the United States, Canada, Lebanon and Egypt use substantial equivalence as the starting point when assessing safety, while many countries such as those in the European Union, Brazil and China authorize GMO cultivation on a case-by-case basis. Many countries allow the import of GM food with authorization, but either do not allow its cultivation or have provisions for cultivation, but no GM products are yet produced. Most countries that do not allow for GMO cultivation do permit research. Most (85%) of the world's GMO crops are grown in the Americas. One of the key issues concerning regulators is whether GM products should be labeled. Labeling of GMO products in the marketplace is required in 64 countries. Labeling can be mandatory up to a threshold GM content level or voluntary. A study investigating voluntary labeling in South Africa found that 31% of products labeled as GMO-free had a GM content above 1.0%. In Canada and the USA labeling of GM food is voluntary, while in Europe all food or feed which contains greater than 0.9% of approved GMOs must be labelled.
The Farmer Assurance Provision refers to Section 735 of US H.R. 933, a bill that was passed by the Senate on March 20, 2013, and then signed into law as part of the Consolidated and Further Continuing Appropriations Act, 2013 by President Barack Obama on March 26, 2013. The provisions of this law remained in effect for six months, until the end of the fiscal year on September 30, 2013. The Farmer Assurance Provision was discontinued in Sec. 101 of the Continuing Appropriations Act, 2014. The bill is commonly referred to as the "Monsanto Protection Act" by its critics.
The March Against Monsanto was an international grassroots movement and protest against Monsanto, a producer of genetically modified organisms (GMOs) and Roundup, a glyphosate-based herbicide. The movement was founded by Tami Canal in response to the failure of California Proposition 37, a ballot initiative which would have required labeling food products made from GMOs. Advocates support mandatory labeling laws for food made from GMOs.
The Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013 is a bill that was introduced into the United States Senate during the 113th United States Congress. The bill would authorize the collection of fees by the Food and Drug Administration for use to fund activities related to the approval of drugs for animals. The bill would amend the Federal Food, Drug, and Cosmetic Act.
The Safe and Accurate Food Labeling Act was an American bill that died in 2016 but not before it influenced Public Law 114-214 in Committee. The purpose of both bills was to amend the Agricultural Marketing Act of 1946. The competitor legislation was signed into law by President Obama on 29 July 2016.
The 21st Century Cures Act is a United States law enacted by the 114th United States Congress in December 2016 and then signed into law on December 13, 2016. It authorized $6.3 billion in funding, mostly for the National Institutes of Health. The act was supported especially by large pharmaceutical manufacturers and was opposed especially by some consumer organizations.
Janet Woodcock is an American physician serving as Principal Deputy Commissioner of Food and Drugs, having previously served as Acting Commissioner of the U.S. Food and Drug Administration (FDA). She joined the FDA in 1986, and has held a number of senior leadership positions there, including terms as the Director of Center for Drug Evaluation and Research (CDER) from 1994 to 2004 and 2007 to 2021.
Rostin Behnam (born February 16, 1978) is an American lawyer and government official who currently serves as the 15th chairman of the Commodity Futures Trading Commission (CFTC). Prior to leading the CFTC, he served as one of five-member CFTC commissioners, having been nominated on July 13, 2017 by President Donald Trump to fulfill a term expiring June 19, 2021. Behnam was unanimously confirmed by the Senate on August 3, 2017, and sworn in as commissioner on September 6, 2017. On January 21, 2021, the commission members unanimously elected Behnam to be acting chairman following President Joe Biden' s inauguration and the resignation of Heath Tarbert, who served as chairman since July 15, 2019. Behnam was re-nominated by President Biden as a commissioner, and simultaneously nominated to chair the agency for a new 5-year term through June 19, 2026. Behnam was unanimously confirmed by the Senate on December 15, 2021, and sworn in as CFTC's chairman and chief administrative officer on January 4, 2022.
Genetic engineering in North America is any genetic engineering activities in North America